+44 (0) 7435 574968
info@orphandrug.co.uk
Start typing & press 'Enter' or 'ESC' to close
EN
Turkish
English
German
Russian
Arabic
Portuguese
Home Page
Corporate
About us
Transparency
MEDICINES
Popular Medicines
Opthalmology
Infectiology
Gynaecology
Pulmonology
Cardiology
Haematology
Neurology
Rheumatology
Dermatology
Hepatology
Endocrinology
Inflammatory Disease
Oncology
Blog
FAQ
Contact
Dermatology
Home Page
Dermatology
Olumiant (baricitinib)
Cibinqo (abrocitinib)
Adbry (tralokinumab-ldrm)
Opzelura (ruxolitinib)
Takhzyro (lanadelumab)
Taltz (ixekizumab)
Skilarence (dimethyl fumarate)
Tremfya (guselkumab)
Stelara (ustekinumab)
Ilumya (tildrakizumab)
Skyrizi (risankizumab)
Zoryve (roflumilast)
Sotyktu (deucravacitinib)
Wezlana (ustekinumab-auub)
Bimzelx (bimekizumab-bkzx)
Simlandi (adalimumab-ryvk)
.png)
Turkish
English
German
Russian
Arabic
Portuguese
